Disparities in anti-nucleocapsid and anti-spike SARS-CoV-2 antibody prevalence in NYC — April–October 2021
SARS-CoV-2 seropositivity was high in 2021 in NYC, with evidence of continued inequities associated with seroprevalence.
Authors
- Emily Spear (ORCID: https://orcid.org/0000-0003-2881-5394)
- Jing Wu (ORCID: https://orcid.org/0000-0002-4941-3370)
- Jo-Anne Caton
- Amber Levanon Seligson
- Steven Fernandez
- L. Hannah Gould (ORCID: https://orcid.org/0000-0001-8971-3311)
- Erik J. Kopping (ORCID: https://orcid.org/0000-0002-0367-1251)
- Randal C. Fowler (ORCID: https://orcid.org/0000-0002-6703-0488)
- Scott Hughes
- Anne Schuster (ORCID: https://orcid.org/0000-0002-0122-1150)
Institutions
- New York City Department of Health and Mental Hygiene (US)
Publication Details
- Journal
- Annals of Epidemiology
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1016/j.annepidem.2024.12.008
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00